Mondrian Investment Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-276,430
| Closed | -$14.8M | – | 139 |
|
|
2016
Q1 | $14.8M | Sell |
276,430
-1,164,198
| -81% | -$62.3M | 0.33% | 58 |
|
|
2015
Q4 | $94.6M | Sell |
1,440,628
-3,944,092
| -73% | -$259M | 2.08% | 13 |
|
|
2015
Q3 | $304M | Sell |
5,384,720
-5,097,549
| -49% | -$288M | 6.44% | 2 |
|
|
2015
Q2 | $620M | Buy |
10,482,269
+26,709
| +0.3% | +$1.58M | 10.5% | 1 |
|
|
2015
Q1 | $651M | Sell |
10,455,560
-573,926
| -5% | -$35.8M | 10.64% | 1 |
|
|
2014
Q4 | $634M | Sell |
11,029,486
-4,895,292
| -31% | -$282M | 10.22% | 1 |
|
|
2014
Q3 | $856M | Sell |
15,924,778
-1,391,100
| -8% | -$74.8M | 11.89% | 1 |
|
|
2014
Q2 | $908M | Sell |
17,315,878
-314,300
| -2% | -$16.5M | 12.74% | 1 |
|
|
2014
Q1 | $932M | Sell |
17,630,178
-4,749,322
| -21% | -$251M | 13.67% | 1 |
|
|
2013
Q4 | $897M | Buy |
22,379,500
+970,339
| +5% | +$38.9M | 12.56% | 1 |
|
|
2013
Q3 | $809M | Buy |
21,409,161
+130,666
| +0.6% | +$4.94M | 11.92% | 1 |
|
|
2013
Q2 | $834M | Buy |
+21,278,495
| New | +$834M | 12.7% | 1 |
|